Aligos Therapeutics, Inc.
Ticker: 1799448
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 | Q3 FY2023 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 2.83+282.4% | 0.74-23.7% | 0.97+212.9% | 0.31-75.2% | 1.25+17.9% | 1.06+53.6% | 0.69-36.7% | 1.09 |
| Total Income | 2.83+282.4% | 0.74-23.7% | 0.97+212.9% | 0.31-75.2% | 1.25+17.9% | 1.06+53.6% | 0.69-36.7% | 1.09 |
| EXPENSES | ||||||||
| Expenditure | 29.76+2.3% | 29.10+49.0% | 19.53-0.1% | 19.55-8.6% | 21.38-22.2% | 27.48+20.8% | 22.74+12.8% | 20.16 |
| Tax | 0.32+433.3% | 0.06-68.4% | 0.19+375.0% | 0.04-55.6% | 0.09-52.6% | 0.19+850.0% | 0.02-33.3% | 0.03 |
| PROFIT | ||||||||
| PBT | -22.72+27.8% | -31.48-100.8% | -15.68-136.4% | 43.13+325.0% | -19.17-465.1% | 5.25+115.1% | -34.84-93.4% | -18.01 |
| Net Profit | -23.04+26.9% | -31.54-98.9% | -15.86-136.8% | 43.09+323.7% | -19.26-480.6% | 5.06+114.5% | -34.86-93.2% | -18.04 |
| KEY METRICS | ||||||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% | -100.00%-200.00pp | 100.00%+200.00pp | -100.00%-200.00pp | 100.00%+200.00pp | -100.00% | -100.00% |
| EPS | -2.21+27.3% | -3.04-98.7% | -1.53-129.9% | 5.12+266.8% | -3.07-10333.3% | 0.03+113.6% | -0.22+46.3% | -0.41 |
Corporate Events
Board MeetingALGS
202625Jun
Board Meeting
Annual Meeting of Stockholders to vote on the election of tw…
SEC Filing ↗